Abstract
Recently, a new oral microemulsion formulation of cyclosporin A (CsA) — Neoral (Sandoz, Basle, Switzerland) — with a higher bioavailability has become available. Ten stable paediatric renal transplant recipients with excessive variations in CsA trough levels with the original Sandimmun (Sandoz, Basle, Switzerland) preparation were switched to Neoral on a 1∶1 basis. Pharmacokinetic studies revealed impaired absorption of Sandimmun, in six patients. Compared with equal doses of Sandimmun, the 8-h area under the concentration-time curve increased from 1,422 to 2,657 ng×h/ml and the peak concentration rose from 319 to 824 ng/ml (P<0.01). In six patients with Sandimmun malabsorption, conversion on a 1∶1 basis led to a reduction in creatinine clearance which was reversible after dose reduction by 9%–25%. With trough levels at the lower end of the present target range, creatinine clearance stabilised around pre-conversion values.
Article PDF
Avoid common mistakes on your manuscript.
Referencesb
Brodehl J, bökenkamp A, Offner G, Hoyer PF (1992) Long-term results in pediatric kidney transplantation: comparison of conventional with cyclosporine A immunosuppression. J Am Soc Nephrol 2: S246-S254
Hoyer PF, Brodehl J, Ehrich JHH, Offner G (1991) Practical aspects in the use of cyclosporin in paediatric nephrology. Pediatr Nephrol 5: 630–638
Ptachcinski RJ, Venkataramanan R, Rosenthal JT, Burckart GJ, Taylor RJ, Hakala TR (1985) The effect of food on cyclosporine absorption. Transplantation 40: 174–176
Maibücher A, Färber L, Weizel D (1993) New galenical formulation of Sandimmun — Sandimmun Optoral — substantially increases the resorption in malabsorbing patients after liver transplantation (abstract). Fundam Clin Pharmacol 7: 370
Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34: 571–590
Holt DW, Mueller EA, Kovarik JM, Bree JB van, Kutz K (1994) The pharmacokinetics of Sandimmun Neoral: A new oral formulation of cyclosporine. Transplant Proc 26: 2935–2939
Kaban BD, Dunn J, Fitts C, Van Buren D, Wombolt D, Pollack R, Carson R, Alexander JW, Chang C, Choc M, Wong R (1994) The trough levels and exposure in stable renal transplant recipients Transplant Proc 26: 2940–2943
Lindholm A, Kahan BD (1993) Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 54: 205–218
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bökenkamp, A., Offner, G., Hoyer, P.F. et al. Improved absorption of cyclosporin A from a new microemulsion formulation: implications for dosage and monitoring. Pediatr Nephrol 9, 196–198 (1995). https://doi.org/10.1007/BF00860745
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00860745